OSL oncosil medical ltd

Ann: Appendix 4D and Half Year Accounts, page-5

  1. 9,313 Posts.
    lightbulb Created with Sketch. 7984
    Surprised no-one discussing these results much. Yes, the promise, recent adoption and early signs of green shoots growth promising, but this company consistently spends too much expense on employees, consulting and just running a company, accordingly, in heavy cash burn. There are a few too many "human" assets being over paid and not adding significant value at this stage.

    The material inputs (I know some stock building, etc) for the revenues are simply too mismatched. Its no wonder this company sold down since the earnings. A cheaper buy-in for me, but poor business figures if we look outside the obvious promise of OSL.


    Last edited by bedger: 27/02/25
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.12
Change
-0.015(1.33%)
Mkt cap ! $20.98M
Open High Low Value Volume
$1.15 $1.15 $1.12 $33.46K 29.79K

Buyers (Bids)

No. Vol. Price($)
1 8108 $1.11
 

Sellers (Offers)

Price($) Vol. No.
$1.12 9032 3
View Market Depth
Last trade - 13.35pm 30/07/2025 (20 minute delay) ?
OSL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.